BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other ...
Researchers at Aarhus University have built a DNA nanostructure shaped like a bacteriophage needle that can recognize ...
As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and ...
Researchers at Northwestern University have built a new type of nanoparticle that triples the efficiency of CRISPR gene ...